Medifast Inc (MED)

SG&A Expense Growth

4.85%

Quarterly · Period ending:

MED logo

MED SG&A Expense Growth

Latest reported4.85%
MED Quarterly SG&A Growth (QoQ) (0.00% → 4.85%)
High-resolution chart · PNG

MED sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Medifast Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
4.8537%
-8.1611%
-9.5063%
-14.76%
-9.1186%
-2.2889%
-15.5048%
-21.1295%
10.0225%
-10.054%
-12.6261%
-11.7093%
-10.8203%
-4.0393%
-14.3571%
-13.943%
10.3233%
6.805%
-8.1136%
8.4439%
18.6592%
21.3783%
1.1249%
21.5517%
17.451%
2.1452%
-10.8502%
8.2184%
12.8674%
12.481%
-0.497%
25.1712%
19.2333%
21.1221%
3.5116%
3.5744%
4.5571%
9.4272%
-6.3458%
-10.3546%
2.717%
18.2492%
-3.6445%
-7.4578%
-5.8276%
116.7997%
-50.6207%
-3.4323%
-5.3816%
-4.5801%
-11.9505%
-7.6819%
-2.4158%
7.8135%
-0.3417%
-9.3589%
8.123%
19.6589%
1.864%
-0.5042%
7.3125%
11.8561%
0.5554%
2.9868%
7.0354%
27.3328%
3.4685%
9.5639%
20.4304%
19.4319%
-1.4649%
-0.4769%
8.4906%
26.1273%
-8.6821%
-3.0657%
16.8802%
18.0098%
-16.1173%
3.2546%
12.3337%
68.6376%
-4.4435%
3.9245%
26.9051%
42.1235%
-22.5953%
9.6184%
-2.6165%
20.6686%
-9.1588%
8.6695%
18.5714%
-5.1267%
156.5382%
-3.9913%
69.9137%
59.6457%
-18.5897%
24.3028%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.